The Quest To Shine Digitally To Keep The Cloudbased Drug Discovery Platform Market On The Toes, Reaching US$ 4,323.5 Mn

New York, United States, 2022-Jun-09 — /EPR Network/ —

The Cloudbased Drug Discovery Platform Market is ascertained to make greater strides in the future. The present-day and futuristic cutting-edge technology, namely IoT, AI, and Big Data operate better in a lightning-fast and reliable internet connection. The benefits of high-speed internet would be seen in telecare in the next 2-3 years, but going forward, more authentic data streams are likely to come up with better-connected devices, thereby revolutionizing the healthcare system.

A new report by Persistence Market Research presents interesting facets of the global cloud-based drug discovery platform market and provides value forecasts for an eight year period from 2017 to 2025. The report titled ‘Cloud-based Drug Discovery Platform Market: Global Industry Analysis (2012 – 2016) and Forecast (2017–2025)’ is a comprehensive take on the global cloud-based drug discovery platform market and highlights the different factors anticipated to impact market revenue growth during the said period.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/11020

According to Persistence Market Research estimations, the global cloud-based drug discovery platform market is projected to be valued at US$ 1,601.1 Mn by the end of 2017 and is expected to reach a market valuation of US$ 4,323.5 Mn by the end of the forecast period in 2025, witnessing a CAGR of 13.2% in terms of value during the forecast period.

Company Profiles:

  • IBM Corporation
  • Accenture PLC
  • Tata Consultancy Services Limited
  • SAS Institute Inc.
  • BioXcel Corporation
  • Cloud Pharmaceuticals Inc.
  • WuXi AppTec (Sanghai) Co. Ltd.
  • Dassault System
  • Acelot, Inc.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/11020

cloud based drug discovery platform market

Global Cloud-based Drug Discovery Platform Market: Dynamics

Revenue drivers

  • Increasing adoption of cloud-based platforms in the healthcare industry to enhance research efficiency
  • Traction in the adoption of machine learning and artificial intelligence for drug discovery
  • Regional healthcare companies adopting cloud-based technologies for collaboration with international healthcare market players

Growth challenges

  • Concerns regarding infrastructure compatibility issues
  • Issues pertaining to interoperability of applications with devices

Market trends

  • Upsurge in the implementation of cloud-based platforms in the healthcare sector across the North America region
  • Rising adoption of cloud-based mobile applications for collaborative drug discovery

Access Full Report@ https://www.persistencemarketresearch.com/checkout/11020

Global Cloud-based Drug Discovery Platform Market: Forecast by End User

The global cloud-based drug discovery platform market is segmented on the basis of end user into Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations, and Others. Pharmaceutical Vendors is expected to be the largest segment in terms of revenue, with a CAGR of 13.4%. Biotech Vendors is the second largest segment in terms of value, estimated to reach a market valuation of US$ 1,247.8 Mn by the end of 2025.

Global Cloud-based Drug Discovery Platform Market: Forecast by Region

Persistence Market Research tracks the performance of the global cloud-based drug discovery platform market across the key regions of North America, Latin America, Europe, Asia Pacific, and MEA. In terms of value, North America is projected to be the most attractive market in the global cloud-based drug discovery platform market during the forecast period. The North America regional market for cloud-based drug discovery platforms is estimated to hold more than 35% value share by the end of the forecast period in 2025. However, the market in APAC is expected to register high Y-o-Y growth rates throughout the forecast period. In terms of value, the APAC cloud-based drug discovery platform market is expected to expand at a CAGR of 16.7% during the forecast period.

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com

Matched content

Editor’s pick

Express Press Release Distribution